المؤلفون: Zhou HL; School of Mechanical Engineering and Automation, Northeastern University, Shenyang, China., Jiang XZ; School of Mechanical Engineering and Automation, Northeastern University, Shenyang, China., Ventikos Y; Department of Mechanical Engineering, Monash University, Melbourne, VIC, Australia.

المصدر: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2023 Oct 13; Vol. 11, pp. 1259280. Date of Electronic Publication: 2023 Oct 13 (Print Publication: 2023).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE

المؤلفون: Krishnamoorthi MK; Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States., Thandavarayan RA; Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States., Youker KA; Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States., Bhimaraj A; Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States.

المصدر: Frontiers in pharmacology [Front Pharmacol] 2022 Jun 23; Vol. 13, pp. 912660. Date of Electronic Publication: 2022 Jun 23 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

المؤلفون: Álvarez E; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Travesía da Choupana s/n, Santiago de Compostela, 15706, A Coruña, Spain.; CIBERCV, Madrid, Spain., Paradela-Dobarro B; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Travesía da Choupana s/n, Santiago de Compostela, 15706, A Coruña, Spain.; CIBERCV, Madrid, Spain., Raposeiras-Roubín S; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Travesía da Choupana s/n, Santiago de Compostela, 15706, A Coruña, Spain.; Servicio de Cardiología y Unidad de Hemodinámica, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Travesía da Choupana s/n, Santiago de Compostela, 15706, A Coruña, Spain., González-Juanatey JR; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Travesía da Choupana s/n, Santiago de Compostela, 15706, A Coruña, Spain.; CIBERCV, Madrid, Spain.; Servicio de Cardiología y Unidad de Hemodinámica, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Travesía da Choupana s/n, Santiago de Compostela, 15706, A Coruña, Spain.

المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2018 Feb; Vol. 84 (2), pp. 280-291. Date of Electronic Publication: 2017 Oct 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Endothelium, Vascular/*drug effects , Factor Xa Inhibitors/*pharmacology , Fibrinolytic Agents/*pharmacology , Protective Agents/*pharmacology , Rivaroxaban/*pharmacology, Cell Movement/drug effects ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Factor Xa Inhibitors/administration & dosage ; Fibrinolytic Agents/administration & dosage ; Human Umbilical Vein Endothelial Cells ; Humans ; Matrix Metalloproteinase 2/genetics ; Protective Agents/administration & dosage ; Rivaroxaban/administration & dosage ; Transcriptome/drug effects ; Urokinase-Type Plasminogen Activator/genetics